Viking Therapeutics (NASDAQ: VKTX) has captured the attention of investors, with its stock price skyrocketing over 400% in ...

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, we will look at where Viking ...

I'm bullish on Viking Therapeutics' weight-loss drug, but warn of risks and competition ahead. Click here to read my most ...

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $70.47 which represents a slight increase of $2.31 or 3.39% from the prior close of $68.16. The stock opened at $69.5 and ...

The general mood among these heavyweight investors is divided, with 57% leaning bullish and 26% bearish. Among these notable ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $64.45 which represents a slight increase of $1.51 or 2.40% from the prior close of $62.94. The stock opened at $63.05 and ...

Viking Therapeutics (VKTX) has received a new Buy rating, initiated by J.P. Morgan analyst, Hardik Parikh. Hardik Parikh has given his Buy ...

The 200-day moving average can provide some of the best long-term entry points. MicroStrategy, Coinbase, and Viking ...

Truist Financial analyst Joon Lee maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) today. The company’s ...

As of 20 September at 15:24 GMT-4. Market open. Adjusted closing price adjusted for splits and dividend and/or capital gain distributions.